<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ksma</journal-id><journal-title-group><journal-title xml:lang="ru">Кубанский научный медицинский вестник</journal-title><trans-title-group xml:lang="en"><trans-title>Kuban Scientific Medical Bulletin</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1608-6228</issn><issn pub-type="epub">2541-9544</issn><publisher><publisher-name>Kuban State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.25207/1608-6228-2018-25-4-124-131</article-id><article-id custom-type="elpub" pub-id-type="custom">ksma-1312</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEW</subject></subj-group></article-categories><title-group><article-title>ЭНДОТЕЛИАЛЬНАЯ ДИСФУНКЦИЯ ПРИ ВОЗДЕЙСТВ ИИ ИОНИЗИРУЮЩЕГО ИЗЛУЧЕНИЯ: ПАТОГЕНЕТИЧЕСКИЕ ОСНОВЫ И В ОЗМОЖНОСТИ ФАРМАКОЛОГИЧЕСКОЙ КОРРЕКЦИИ</article-title><trans-title-group xml:lang="en"><trans-title>ENDOTHELIAL DYSFUNCTION UNDER INFLUENCE OF IONIZING RADIATION: PATHOGENETIC BASIS AND OPPORTUNITIES OF PHARMACOLOGICAL CORRECTION</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>САРОЯН</surname><given-names>К. В.</given-names></name><name name-style="western" xml:lang="en"><surname>SAROYAN</surname><given-names>K. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ул. Победы, д. 85, г. Белгород, Россия, 308015</p><p>тел.: +7 (910) 325-84-96</p><p>Россия, Курск, 305021, ул. Школьная, д. 48А, кв. 88.</p></bio><bio xml:lang="en"><p>85 Pobedy str., Belgorod, Russia, 308015</p><p>tel.: +7 (910) 325-84-96</p></bio><email xlink:type="simple">saroyan_1981@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>СЫТНИК</surname><given-names>И. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>SYTNIK</surname><given-names>I. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ул. Победы, д. 85, г. Белгород, Россия, 308015</p></bio><bio xml:lang="en"><p>85 Pobedy str., Belgorod, Russia, 308015</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>СОЛДАТОВ</surname><given-names>В. О.</given-names></name><name name-style="western" xml:lang="en"><surname>SOLDATOV</surname><given-names>V. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ул. Победы, д. 85, г. Белгород, Россия, 308015</p></bio><bio xml:lang="en"><p>85 Pobedy str., Belgorod, Russia, 308015</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>ПЕРШИНА</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>PERSHINA</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ул. Победы, д. 85, г. Белгород, Россия, 308015</p></bio><bio xml:lang="en"><p>85 Pobedy str., Belgorod, Russia, 308015</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>ЖЕРНАКОВА</surname><given-names>Н. И.</given-names></name><name name-style="western" xml:lang="en"><surname>ZHERNAKOVA</surname><given-names>N. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ул. Победы, д. 85, г. Белгород, Россия, 308015</p></bio><bio xml:lang="en"><p>85 Pobedy str., Belgorod, Russia, 308015</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>ПОВЕТКИН</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>POVETKIN</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ул. Победы, д. 85, г. Белгород, Россия, 308015</p></bio><bio xml:lang="en"><p>85 Pobedy str., Belgorod, Russia, 308015</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>СЕРНОВ</surname><given-names>Л. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>SERNOV</surname><given-names>L. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ул. Победы, д. 85, г. Белгород, Россия, 308015</p></bio><bio xml:lang="en"><p>85 Pobedy str., Belgorod, Russia, 308015</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Белгородский национальный исследовательский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Belgorod National Research University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>03</day><month>10</month><year>2018</year></pub-date><volume>25</volume><issue>4</issue><fpage>124</fpage><lpage>131</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; САРОЯН К.В., СЫТНИК И.Н., СОЛДАТОВ В.О., ПЕРШИНА М.А., ЖЕРНАКОВА Н.И., ПОВЕТКИН С.В., СЕРНОВ Л.Н., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">САРОЯН К.В., СЫТНИК И.Н., СОЛДАТОВ В.О., ПЕРШИНА М.А., ЖЕРНАКОВА Н.И., ПОВЕТКИН С.В., СЕРНОВ Л.Н.</copyright-holder><copyright-holder xml:lang="en">SAROYAN K.V., SYTNIK I.N., SOLDATOV V.O., PERSHINA M.A., ZHERNAKOVA N.I., POVETKIN S.V., SERNOV L.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://ksma.elpub.ru/jour/article/view/1312">https://ksma.elpub.ru/jour/article/view/1312</self-uri><abstract><p>Проблема радиационно-индуцированных поражений становится все более актуальной. Исследования последних лет показывают, что одной из наиболее уязвимых тканей при  воздействии высоких доз ионизирующего излучения является эндотелий. Изучение  патогенетических основ данного явления показало, что повреждение эндотелиоцитов  происходит как за счет прямого воздействия радиации, так и за счет системного нарушения  гомеостаза, приводящего к дезадаптации исполнительных и регуляторных систем организма. В  данном обзоре рассмотрены механизмы развития эндотелиальной дисфункции при воздействии  радиоактивного излучения и возможные способы фармакологической коррекции данного состояния.</p></abstract><trans-abstract xml:lang="en"><p>The problem of radiation-induced lesions is becoming increasingly urgent. Studies in recent years show that one of the most vulnerable  tissues is the endothelium when exposed to high doses of ionizing  radiation. The study of the pathogenetic bases of this phenomenon has  shown that damage to endotheliocytes occurs both at the expense of  the direct exposure to radiation and due to the systemic disturbance of  homeostasis which leads to the disadaptation of the executive and  regulatory systems of the organism. In this review we considered the  mechanisms of the development of endothelial dysfunction under the influence of radioactive radiation and possible methods of pharmacological correction of this condition.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>эндотелиальная дисфункция</kwd><kwd>радиация</kwd><kwd>радиопротекторы</kwd><kwd>эндотелиопротекторы</kwd></kwd-group><kwd-group xml:lang="en"><kwd>endothelial dysfunction</kwd><kwd>radiation</kwd><kwd>radioprotectors</kwd><kwd>endothelioprotectors</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Azizova T., Grigoryeva E., Haylock R., Pikulina M., Moseeva M. Ischaemic heart disease incidence and mortality in an extended cohort of Mayak workers first employed in 1948– 1982. The British Journal of Radiology. 2015; 88(1054): 20150169. DOI: 10.1259/bjr.20150169.</mixed-citation><mixed-citation xml:lang="en">Azizova T., Grigoryeva E., Haylock R., Pikulina M., Moseeva M. Ischaemic heart disease incidence and mortality in an extended cohort of Mayak workers first employed in 1948– 1982. The British Journal of Radiology. 2015; 88(1054): 20150169. DOI: 10.1259/bjr.20150169.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Moseeva M., Azizova T., Grigoryeva E., Haylock R. Risks of circulatory diseases among Mayak PA workers with radiation doses estimated using the improved Mayak Worker Dosimetry System 2008. Radiation and Environmental Biophysics. 2014; 53: 469-477. DOI: 10.1007/s00411-014-0517-x.</mixed-citation><mixed-citation xml:lang="en">Moseeva M., Azizova T., Grigoryeva E., Haylock R. Risks of circulatory diseases among Mayak PA workers with radiation doses estimated using the improved Mayak Worker Dosimetry System 2008. Radiation and Environmental Biophysics. 2014; 53: 469-477. DOI: 10.1007/s00411-014-0517-x.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Adams M., Hardenbergh P., Constine L., Lipshultz S. Radiation- associated cardiovascular disease. Critical Reviews In Oncology Hematology. 2003; 45(1): 55-75.</mixed-citation><mixed-citation xml:lang="en">Adams M., Hardenbergh P., Constine L., Lipshultz S. Radiation- associated cardiovascular disease. Critical Reviews In Oncology Hematology. 2003; 45(1): 55-75.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Little M., Tawn E., Tzoulaki I. A systematic review of epidemiological associations between low and moderate doses of ionizing radiation and late cardiovascular effects, and their possible mechanisms. Journal of Radiation Research. 2008; 169: 99-109. DOI: 10.1667/RR1070.1.</mixed-citation><mixed-citation xml:lang="en">Little M., Tawn E., Tzoulaki I. A systematic review of epidemiological associations between low and moderate doses of ionizing radiation and late cardiovascular effects, and their possible mechanisms. Journal of Radiation Research. 2008; 169: 99-109. DOI: 10.1667/RR1070.1.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Gimbrone M., García-Cardeña G. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circulation Research. 2016; 118: 620-636. DOI: 10.1161/CIRCRESAHA.115.306301.</mixed-citation><mixed-citation xml:lang="en">Gimbrone M., García-Cardeña G. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circulation Research. 2016; 118: 620-636. DOI: 10.1161/CIRCRESAHA.115.306301.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Kumarathasan P., Vincent R., Blais E., Saravanamuthu A., Gupta P., Wyatt H., Mitchel R., Hannan M., Trivedi A., Whitman S. Cardiovascular changes in atherosclerotic ApoE-deficient mice exposed to Co60 (γ) radiation. PLoS One. 2013; 8(6): e65486. DOI: 10.1371/journal.pone.0065486.</mixed-citation><mixed-citation xml:lang="en">Kumarathasan P., Vincent R., Blais E., Saravanamuthu A., Gupta P., Wyatt H., Mitchel R., Hannan M., Trivedi A., Whitman S. Cardiovascular changes in atherosclerotic ApoE-deficient mice exposed to Co60 (γ) radiation. PLoS One. 2013; 8(6): e65486. DOI: 10.1371/journal.pone.0065486.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Rom O., Reznick A. The stress reaction: a historical perspective. Advances in Experimental Medicine and Biology. 2016; 905: 1-4. DOI: 10.1007/5584_2015_195.</mixed-citation><mixed-citation xml:lang="en">Rom O., Reznick A. The stress reaction: a historical perspective. Advances in Experimental Medicine and Biology. 2016; 905: 1-4. DOI: 10.1007/5584_2015_195.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Coppe J., Patil C., Rodier F. Senescence-associated secretory phenotypes reveal cell- nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biology. 2016; 6: 2853- 68. DOI: 10.1371/journal.pbio.0060301.</mixed-citation><mixed-citation xml:lang="en">Coppe J., Patil C., Rodier F. Senescence-associated secretory phenotypes reveal cell- nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biology. 2016; 6: 2853- 68. DOI: 10.1371/journal.pbio.0060301.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Heckmann M., Douwes K., Peter R., Degitz K. Vascular activation of adhesion molecule mRNA and cell surface expression by ionizing radiation. Experimental Cell Research. 1998; 238(1): 148-54. DOI: 10.1006/excr.1997.3826.</mixed-citation><mixed-citation xml:lang="en">Heckmann M., Douwes K., Peter R., Degitz K. Vascular activation of adhesion molecule mRNA and cell surface expression by ionizing radiation. Experimental Cell Research. 1998; 238(1): 148-54. DOI: 10.1006/excr.1997.3826.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Adams G., Jameson D. Time effects in molecular radiation biology. Radiation and Environmental Biophysics. 1980; 17(2): 95- 11310.</mixed-citation><mixed-citation xml:lang="en">Adams G., Jameson D. Time effects in molecular radiation biology. Radiation and Environmental Biophysics. 1980; 17(2): 95- 11310.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Childs B., Durik M., Baker D., van Deursen J. Cellular senescence in aging and age-related disease: From mechanisms to therapy. Nature Medicine. 2015; 21:1424-1435. DOI: 10.1038/nm.4000.</mixed-citation><mixed-citation xml:lang="en">Childs B., Durik M., Baker D., van Deursen J. Cellular senescence in aging and age-related disease: From mechanisms to therapy. Nature Medicine. 2015; 21:1424-1435. DOI: 10.1038/nm.4000.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Wang Y., Boerma M., Zhou D. Ionizing radiation-induced endothelial cell senescence and cardiovascular diseases. Journal of Radiation Research. 2016; 186(2): 153-161. DOI: 10.1667/RR14445.1.</mixed-citation><mixed-citation xml:lang="en">Wang Y., Boerma M., Zhou D. Ionizing radiation-induced endothelial cell senescence and cardiovascular diseases. Journal of Radiation Research. 2016; 186(2): 153-161. DOI: 10.1667/RR14445.1.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Schultz-Hector S., Balz K. Radiation-induced loss of endothelial alkaline phosphatase activity and development of myocardial degeneration. An ultrastructural study. Laboratory Investigation; a Journal of Technical Methods and Pathology. 1994; 71(2): 252-260.</mixed-citation><mixed-citation xml:lang="en">Schultz-Hector S., Balz K. Radiation-induced loss of endothelial alkaline phosphatase activity and development of myocardial degeneration. An ultrastructural study. Laboratory Investigation; a Journal of Technical Methods and Pathology. 1994; 71(2): 252-260.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Vieira D., Gloaguen C., Kereselidze D., Manens L., Tack K., Ebrahimian T. Gamma Low- Dose-Rate Ionizing Radiation Stimulates Adaptive Functional and Molecular Response in Human Aortic Endothelial Cells in a Threshold-, Dose-, and Dose Rate-Dependent Manner. Dose Response 2018; 16(1): 1559325818755238. DOI: 10.1177/1559325818755238.</mixed-citation><mixed-citation xml:lang="en">Vieira D., Gloaguen C., Kereselidze D., Manens L., Tack K., Ebrahimian T. Gamma Low- Dose-Rate Ionizing Radiation Stimulates Adaptive Functional and Molecular Response in Human Aortic Endothelial Cells in a Threshold-, Dose-, and Dose Rate-Dependent Manner. Dose Response 2018; 16(1): 1559325818755238. DOI: 10.1177/1559325818755238.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Langley R., Bump E., Quartuccio S., Medeiros D., Braunhut S. Radiation-induced apoptosis in microvascular endothelial cells. The British Journal of Cancer 1997; 75: 666.</mixed-citation><mixed-citation xml:lang="en">Langley R., Bump E., Quartuccio S., Medeiros D., Braunhut S. Radiation-induced apoptosis in microvascular endothelial cells. The British Journal of Cancer 1997; 75: 666.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Zhong G., Chen F., Bu D., Wang S., Pang Y., Tang C. Cobalt-60 gamma radiation increased the nitric oxide generation in cultured rat vascular smooth muscle cells. Life Science Journal 2004; 74(25): 3055-3063. DOI: 10.1016/j.lfs.2003.08.049.</mixed-citation><mixed-citation xml:lang="en">Zhong G., Chen F., Bu D., Wang S., Pang Y., Tang C. Cobalt-60 gamma radiation increased the nitric oxide generation in cultured rat vascular smooth muscle cells. Life Science Journal 2004; 74(25): 3055-3063. DOI: 10.1016/j.lfs.2003.08.049.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Donato A., Morgan R., Walker A., Lesniewski L. Cellular and molecular biology of aging endothelial cells. Journal of Molecular and Cellular Cardiology. 2015; 89: 122-35. DOI: 10.1016/j.yjmcc.2015.01.021.</mixed-citation><mixed-citation xml:lang="en">Donato A., Morgan R., Walker A., Lesniewski L. Cellular and molecular biology of aging endothelial cells. Journal of Molecular and Cellular Cardiology. 2015; 89: 122-35. DOI: 10.1016/j.yjmcc.2015.01.021.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Higashi Y., Kihara Y., Noma K. Endothelial dysfunction and hypertension in aging. Hypertension Research. 2012; 35:1039-47. DOI: 10.1038/hr.2012.138.</mixed-citation><mixed-citation xml:lang="en">Higashi Y., Kihara Y., Noma K. Endothelial dysfunction and hypertension in aging. Hypertension Research. 2012; 35:1039-47. DOI: 10.1038/hr.2012.138.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Beausejour C., Krtolica A., Galimi F., Narita M., Lowe S., Yaswen P. Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO Journal 2003; 22:4212-22. DOI: 10.1093/emboj/cdg417.</mixed-citation><mixed-citation xml:lang="en">Beausejour C., Krtolica A., Galimi F., Narita M., Lowe S., Yaswen P. Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO Journal 2003; 22:4212-22. DOI: 10.1093/emboj/cdg417.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Leach J., Black S., Schmidt-Ullrich R., Аikkelsen R. Activation of constitutive nitric-oxide synthase activity is an early signaling event induced by ionizing radiation. Journal of Biological Chemistry 2002; 277(18): 15400-15406. DOI: 10.1074/jbc.M110309200.</mixed-citation><mixed-citation xml:lang="en">Leach J., Black S., Schmidt-Ullrich R., Аikkelsen R. Activation of constitutive nitric-oxide synthase activity is an early signaling event induced by ionizing radiation. Journal of Biological Chemistry 2002; 277(18): 15400-15406. DOI: 10.1074/jbc.M110309200.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Oesterle A., Laufs U., Liao J.K. Pleiotropic effects of statins on the cardiovascular system. Circulation Research. 2017; 120: 229-43. DOI: 10.1161/CIRCRESAHA.116.308537.</mixed-citation><mixed-citation xml:lang="en">Oesterle A., Laufs U., Liao J.K. Pleiotropic effects of statins on the cardiovascular system. Circulation Research. 2017; 120: 229-43. DOI: 10.1161/CIRCRESAHA.116.308537.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Di Micco R., Fumagalli M., Cicalese A., Piccinin S., Gasparini P., Luise C., Schurra C., Garre M., Nuciforo P., Bensimon A., Maestro R., Pelicci P., d'Adda di Fagagna F. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 2006; 444: 638-642. DOI: 10.1038/nature05327.</mixed-citation><mixed-citation xml:lang="en">Di Micco R., Fumagalli M., Cicalese A., Piccinin S., Gasparini P., Luise C., Schurra C., Garre M., Nuciforo P., Bensimon A., Maestro R., Pelicci P., d'Adda di Fagagna F. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 2006; 444: 638-642. DOI: 10.1038/nature05327.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Epperly M., Gretton J., DeFilippi S., Greenberger J., Sikora C., Liggitt D., Koe, G., Greenberger J. Modulation of radiation-induced cytokine elevation associated with esophagitis and esophageal stricture by manganese superoxide dismutaseplasmid/liposome (SOD2-PL) gene therapy. Journal of Radiation Research. 2001; 155:2-14.</mixed-citation><mixed-citation xml:lang="en">Epperly M., Gretton J., DeFilippi S., Greenberger J., Sikora C., Liggitt D., Koe, G., Greenberger J. Modulation of radiation-induced cytokine elevation associated with esophagitis and esophageal stricture by manganese superoxide dismutaseplasmid/liposome (SOD2-PL) gene therapy. Journal of Radiation Research. 2001; 155:2-14.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Epperly M., Kagan V., Sikora C., Gretton J., Defilippi S., Bar-Sagi D. Manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) administration protects mice from esophagitis associated with fractionated radiation. International Journal of Cancer. 2001; 96(4): 221-31.</mixed-citation><mixed-citation xml:lang="en">Epperly M., Kagan V., Sikora C., Gretton J., Defilippi S., Bar-Sagi D. Manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) administration protects mice from esophagitis associated with fractionated radiation. International Journal of Cancer. 2001; 96(4): 221-31.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Pitt B. Effects of ACE inhibitors on endothelial dysfunction: unanswered questions and implications for further investigation and therapy. Cardiovasc Drugs Ther. 1996; 10(4): 469-73.</mixed-citation><mixed-citation xml:lang="en">Pitt B. Effects of ACE inhibitors on endothelial dysfunction: unanswered questions and implications for further investigation and therapy. Cardiovasc Drugs Ther. 1996; 10(4): 469-73.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Patarroyo Aponte M.M., Francis G.S. Effect of angiotensinconverting enzyme inhibitors and angiotensin receptor antagonists in atherosclerosis prevention. Curr Cardiol Rep. 2012; 14(4): 433- 442.</mixed-citation><mixed-citation xml:lang="en">Patarroyo Aponte M.M., Francis G.S. Effect of angiotensinconverting enzyme inhibitors and angiotensin receptor antagonists in atherosclerosis prevention. Curr Cardiol Rep. 2012; 14(4): 433- 442.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Robbins M., Diz D. Pathogenic role of the renin-angiotensin system in modulating radiation-induced late effects. International Journal of Radiation Oncology Biology Physics. 2006; 64(1): 6-1210. DOI: 10.1016/j.ijrobp.2005.08.033.</mixed-citation><mixed-citation xml:lang="en">Robbins M., Diz D. Pathogenic role of the renin-angiotensin system in modulating radiation-induced late effects. International Journal of Radiation Oncology Biology Physics. 2006; 64(1): 6-1210. DOI: 10.1016/j.ijrobp.2005.08.033.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Robbins M., Hopewell J. Physiological factors effecting renal radiation tolerance: a guide to the treatment of late effects. The British Journal of Cancer. 1986; 7: 265-7.</mixed-citation><mixed-citation xml:lang="en">Robbins M., Hopewell J. Physiological factors effecting renal radiation tolerance: a guide to the treatment of late effects. The British Journal of Cancer. 1986; 7: 265-7.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Davis T., Landauer M., Mog S., Barshishat-Kupper M., Zins S., Amare M. Timing of captopril administration determines radiation protection or radiation sensitization in a murine model of total body irradiation. Experimental Hematology. 2010; 38(4): 270-81. DOI: 10.1016/j.exphem.2011.02.006.</mixed-citation><mixed-citation xml:lang="en">Davis T., Landauer M., Mog S., Barshishat-Kupper M., Zins S., Amare M. Timing of captopril administration determines radiation protection or radiation sensitization in a murine model of total body irradiation. Experimental Hematology. 2010; 38(4): 270-81. DOI: 10.1016/j.exphem.2011.02.006.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Kma L., Gao F., Fish B., Moulder J., Jacobs E., Medhora M. Angiotensin converting enzyme inhibitors mitigate collagen synthesis induced by a single dose of radiation to the whole thorax. Journal of Radiation Research. 2012; 53(1):10-7.</mixed-citation><mixed-citation xml:lang="en">Kma L., Gao F., Fish B., Moulder J., Jacobs E., Medhora M. Angiotensin converting enzyme inhibitors mitigate collagen synthesis induced by a single dose of radiation to the whole thorax. Journal of Radiation Research. 2012; 53(1):10-7.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Medhora M., Gao F., Jacobs E., Moulder J. Radiation damage to the lung: mitigation by angiotensin-converting enzyme (ACE) inhibitors. Respirology. 2012; 17(1): 66-71. DOI: 10.1111/j.1440-1843.2011.02092.x.</mixed-citation><mixed-citation xml:lang="en">Medhora M., Gao F., Jacobs E., Moulder J. Radiation damage to the lung: mitigation by angiotensin-converting enzyme (ACE) inhibitors. Respirology. 2012; 17(1): 66-71. DOI: 10.1111/j.1440-1843.2011.02092.x.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Ward W., Kim Y., Molteni A., Solliday N. Radiation-induced pulmonary endothelial dysfunction in rats: modification by an inhibitor of angiotensin converting enzyme. International Journal of Radiation Oncology Biology Physics. 1988; 15(1): 135-40.</mixed-citation><mixed-citation xml:lang="en">Ward W., Kim Y., Molteni A., Solliday N. Radiation-induced pulmonary endothelial dysfunction in rats: modification by an inhibitor of angiotensin converting enzyme. International Journal of Radiation Oncology Biology Physics. 1988; 15(1): 135-40.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Ward W., Molteni A., Ts’ao C., Hinz J. The effect of captopril on benign and malignant reactions in irradiated rat skin. The British Journal of Radiology. 1990; 63(749): 349-54. DOI: 10.1259/0007-1285-63-749-349.</mixed-citation><mixed-citation xml:lang="en">Ward W., Molteni A., Ts’ao C., Hinz J. The effect of captopril on benign and malignant reactions in irradiated rat skin. The British Journal of Radiology. 1990; 63(749): 349-54. DOI: 10.1259/0007-1285-63-749-349.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Cohen E., Fish B., Moulder J. Treatment of radiation nephropathy with ACE inhibitors. Journal of Radiation Research. 1992; 132(3): 346-50.</mixed-citation><mixed-citation xml:lang="en">Cohen E., Fish B., Moulder J. Treatment of radiation nephropathy with ACE inhibitors. Journal of Radiation Research. 1992; 132(3): 346-50.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Cohen E., Irving A., Drobyski W., Klein J., Passweg J., Talano J. Captopril to mitigate chronic renal failure after hematopoietic stem cell transplantation: a randomized controlled trial. International Journal of Radiation Oncology Biology Physics. 2008; 70(5): 1546-51. DOI: 10.1016/j.ijrobp.2007.08.041.</mixed-citation><mixed-citation xml:lang="en">Cohen E., Irving A., Drobyski W., Klein J., Passweg J., Talano J. Captopril to mitigate chronic renal failure after hematopoietic stem cell transplantation: a randomized controlled trial. International Journal of Radiation Oncology Biology Physics. 2008; 70(5): 1546-51. DOI: 10.1016/j.ijrobp.2007.08.041.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Charrier S., Michaud A., Badaoui S., Giroux S., Ezan E., Sainteny F. Inhibition of angiotensin I-converting enzyme induces radioprotection by preserving murine hematopoietic short-term reconstituting cells. Blood. 2004; 104(4): 978-85. DOI: 10.1182/blood-2003-11-3828.</mixed-citation><mixed-citation xml:lang="en">Charrier S., Michaud A., Badaoui S., Giroux S., Ezan E., Sainteny F. Inhibition of angiotensin I-converting enzyme induces radioprotection by preserving murine hematopoietic short-term reconstituting cells. Blood. 2004; 104(4): 978-85. DOI: 10.1182/blood-2003-11-3828.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Hu P., Li B., Zhang W., Li Y., Li G., Jiang X. AcSDKP regulates cell proliferation through the PI3KCA/Akt signaling pathway. PLoS ONE. 2013; 8(11): e79321. DOI: 10.1371/journal.pone.0079321.</mixed-citation><mixed-citation xml:lang="en">Hu P., Li B., Zhang W., Li Y., Li G., Jiang X. AcSDKP regulates cell proliferation through the PI3KCA/Akt signaling pathway. PLoS ONE. 2013; 8(11): e79321. DOI: 10.1371/journal.pone.0079321.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Chisi J., Briscoe C., Ezan E., Genet R., Riches A., Wdzieczak-Bakala J. Captopril inhibits in vitro and in vivo the proliferation of primitive haematopoietic cells induced into cell cycle by cytotoxic drug administration or irradiation but has no effect on myeloid leukaemia cell proliferation. British Journal of Haematology. 2000; 109(3): 563-70.</mixed-citation><mixed-citation xml:lang="en">Chisi J., Briscoe C., Ezan E., Genet R., Riches A., Wdzieczak-Bakala J. Captopril inhibits in vitro and in vivo the proliferation of primitive haematopoietic cells induced into cell cycle by cytotoxic drug administration or irradiation but has no effect on myeloid leukaemia cell proliferation. British Journal of Haematology. 2000; 109(3): 563-70.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Day R., Davis T., Barshishat-Kupper M., McCart E., Tipton A., Landauer M. Enhanced hematopoietic protection from radiation by the combination of genistein and captopril. International Journal of Pharmacology. 2013; 15(2): 348-56. DOI: 10.1016/j.intimp.2012.12.029.</mixed-citation><mixed-citation xml:lang="en">Day R., Davis T., Barshishat-Kupper M., McCart E., Tipton A., Landauer M. Enhanced hematopoietic protection from radiation by the combination of genistein and captopril. International Journal of Pharmacology. 2013; 15(2): 348-56. DOI: 10.1016/j.intimp.2012.12.029.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Moon C., Krawczyk M., Paik D., Coleman T., Brines M., Juhaszova M. Erythropoietin, modified to not stimulate red blood cell production, retains its cardioprotective properties. Journal of Pharmacology and Experimental Therapeutics. 2006; 316: 999-1005. DOI: 10.1124/jpet.105.094854.</mixed-citation><mixed-citation xml:lang="en">Moon C., Krawczyk M., Paik D., Coleman T., Brines M., Juhaszova M. Erythropoietin, modified to not stimulate red blood cell production, retains its cardioprotective properties. Journal of Pharmacology and Experimental Therapeutics. 2006; 316: 999-1005. DOI: 10.1124/jpet.105.094854.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Um M., Gross A., Lodish H. A “Classical” homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells. Cellular Signalling. 2007; 19: 634- 45. DOI: 10.1016/j.cellsig.2006.08.014.</mixed-citation><mixed-citation xml:lang="en">Um M., Gross A., Lodish H. A “Classical” homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells. Cellular Signalling. 2007; 19: 634- 45. DOI: 10.1016/j.cellsig.2006.08.014.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Assaraf M., Diaz Z., Liberman A., Miller W., Jr., Arvanitakis Z., Li Y. Brain erythropoietin receptor expression in Alzheimer disease and mild cognitive impairment. Journal of Neuropathology &amp; Experimental Neurology. 2007; 66: 389-98. DOI: 10.1097/nen.0b013e3180517b28.</mixed-citation><mixed-citation xml:lang="en">Assaraf M., Diaz Z., Liberman A., Miller W., Jr., Arvanitakis Z., Li Y. Brain erythropoietin receptor expression in Alzheimer disease and mild cognitive impairment. Journal of Neuropathology &amp; Experimental Neurology. 2007; 66: 389-98. DOI: 10.1097/nen.0b013e3180517b28.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Palazzuoli A., Silverberg D., Iovine F., Capobianco S., Giannotti G., Calabro A. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia. American Heart Journal. 2006; 152:1096-15. DOI: 10.1016/j.ahj.2006.08.005.</mixed-citation><mixed-citation xml:lang="en">Palazzuoli A., Silverberg D., Iovine F., Capobianco S., Giannotti G., Calabro A. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia. American Heart Journal. 2006; 152:1096-15. DOI: 10.1016/j.ahj.2006.08.005.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Anagnostou A., Lee E., Kessimian N., Levinson R., Steiner M. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proceedings of the National Academy of Sciences. 1990; 87: 5978-82.</mixed-citation><mixed-citation xml:lang="en">Anagnostou A., Lee E., Kessimian N., Levinson R., Steiner M. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proceedings of the National Academy of Sciences. 1990; 87: 5978-82.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Catlin D., Breidbach A., Elliott S., Glaspy J. Comparison of the isoelectric focusing patterns of darbepoetin alfa, recombinant human erythropoietin, and endogenous erythropoietin from human urine. Clinical Chemistry. 2002; 48: 2057-9.</mixed-citation><mixed-citation xml:lang="en">Catlin D., Breidbach A., Elliott S., Glaspy J. Comparison of the isoelectric focusing patterns of darbepoetin alfa, recombinant human erythropoietin, and endogenous erythropoietin from human urine. Clinical Chemistry. 2002; 48: 2057-9.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Shabelnikova A.S. Correction of ischemic damage to the retina on application of pharmacological preconditioning of recombinant erythropoietin. Research result: pharmacology and clinical pharmacology. 2016; 2(2): 67-90.</mixed-citation><mixed-citation xml:lang="en">Shabelnikova A.S. Correction of ischemic damage to the retina on application of pharmacological preconditioning of recombinant erythropoietin. Research result: pharmacology and clinical pharmacology. 2016; 2(2): 67-90.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Denisiuk T.A. Pharmacotherapeutic strategies for endothelial dysfunction correction with use of statines in syndrome of systemic inflammatory response. Research Result: Pharmacology and Clinical Pharmacology. 2017; 3(4): 35-77. DOI: 10.18413/2313-8971-2017-3-4-35-77.</mixed-citation><mixed-citation xml:lang="en">Denisiuk T.A. Pharmacotherapeutic strategies for endothelial dysfunction correction with use of statines in syndrome of systemic inflammatory response. Research Result: Pharmacology and Clinical Pharmacology. 2017; 3(4): 35-77. DOI: 10.18413/2313-8971-2017-3-4-35-77.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Brunner S., Winogradow J., Huber B., Zaruba M.M., Fischer R., David R. Erythropoietin administration after myocardial infarction in mice attenuates ischemic cardiomyopathy associated with enhanced homing of bone marrow-derived progenitor cells via the CXCR- 4/SDF-1 axis. FASEB Journal. 2009; 23: 351-61. DOI: 10.1096/fj.08-109462.</mixed-citation><mixed-citation xml:lang="en">Brunner S., Winogradow J., Huber B., Zaruba M.M., Fischer R., David R. Erythropoietin administration after myocardial infarction in mice attenuates ischemic cardiomyopathy associated with enhanced homing of bone marrow-derived progenitor cells via the CXCR- 4/SDF-1 axis. FASEB Journal. 2009; 23: 351-61. DOI: 10.1096/fj.08-109462.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Lin J., Chen Y., Chiang H., Ma M. Hypoxic preconditioning protects rat hearts against ischaemia-reperfusion injury: role of erythropoietin on progenitor cell mobilization. The Journal of Physiology. 2008; 586: 5757-69. DOI: 10.1113/jphysiol.2008.160887.</mixed-citation><mixed-citation xml:lang="en">Lin J., Chen Y., Chiang H., Ma M. Hypoxic preconditioning protects rat hearts against ischaemia-reperfusion injury: role of erythropoietin on progenitor cell mobilization. The Journal of Physiology. 2008; 586: 5757-69. DOI: 10.1113/jphysiol.2008.160887.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Ribeiro M., Silva A., Rodrigues J., Naia L., Rego A. Oxidizing effects of exogenous stressors in Huntington's disease knock-in striatal cells-protective effect of cystamine and creatine. Toxicological Sciences. 2013; 136: 487-499. DOI 10.1093/toxsci/kft199.</mixed-citation><mixed-citation xml:lang="en">Ribeiro M., Silva A., Rodrigues J., Naia L., Rego A. Oxidizing effects of exogenous stressors in Huntington's disease knock-in striatal cells-protective effect of cystamine and creatine. Toxicological Sciences. 2013; 136: 487-499. DOI 10.1093/toxsci/kft199.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Borrell-Pages M., Canals J., Cordelieres F., Parker J., Pineda J., Grange G. Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase. The Journal of Clinical Investigation. 2006; 116: 1410-1424. DOI 10.1172/JCI27607.</mixed-citation><mixed-citation xml:lang="en">Borrell-Pages M., Canals J., Cordelieres F., Parker J., Pineda J., Grange G. Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase. The Journal of Clinical Investigation. 2006; 116: 1410-1424. DOI 10.1172/JCI27607.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Aleman M., Holle L., Stember K., Devette C., Monroe D., Wolberg A. Cystamine preparations exhibit anticoagulant activity. PLoS One. 2015; 10(4): e0124448. DOI 10.1371/journal.pone.0124448.</mixed-citation><mixed-citation xml:lang="en">Aleman M., Holle L., Stember K., Devette C., Monroe D., Wolberg A. Cystamine preparations exhibit anticoagulant activity. PLoS One. 2015; 10(4): e0124448. DOI 10.1371/journal.pone.0124448.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Lee F., Sun C., Sung P., Chen K., Chua S., Sheu J., Chung S., Chai H., Chen Y., Huang T., Huang C., Li Y., Luo C., Yip H. Daily melatonin protects the endothelial lineage and functional integrity against the aging process, oxidative stress, and toxic environment and restores blood flow in critical limb ischemia area in mice. Journal of Pineal Research. 2018; 127: 201- 1440. DOI 10.1111/jpi.12489.</mixed-citation><mixed-citation xml:lang="en">Lee F., Sun C., Sung P., Chen K., Chua S., Sheu J., Chung S., Chai H., Chen Y., Huang T., Huang C., Li Y., Luo C., Yip H. Daily melatonin protects the endothelial lineage and functional integrity against the aging process, oxidative stress, and toxic environment and restores blood flow in critical limb ischemia area in mice. Journal of Pineal Research. 2018; 127: 201- 1440. DOI 10.1111/jpi.12489.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Carrillo-Vico A, Lardone P. J, Alvarez-Sánchez N, Rodríguez-Rodríguez A, Guerrero J. Melatonin: buffering the immune system. International Journal of Molecular Sciences. 2013; 14: 8638-8683. DOI 10.3390/ijms14048638.</mixed-citation><mixed-citation xml:lang="en">Carrillo-Vico A, Lardone P. J, Alvarez-Sánchez N, Rodríguez-Rodríguez A, Guerrero J. Melatonin: buffering the immune system. International Journal of Molecular Sciences. 2013; 14: 8638-8683. DOI 10.3390/ijms14048638.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Baker J., Kimpinski K. Role of melatonin in blood pressure regulation: An adjunct anti- hypertensive agent. Clinical and Experimental Pharmacology and Physiology. 2018; 10: 1440-1681. DOI 10.1111/1440-1681.12942.</mixed-citation><mixed-citation xml:lang="en">Baker J., Kimpinski K. Role of melatonin in blood pressure regulation: An adjunct anti- hypertensive agent. Clinical and Experimental Pharmacology and Physiology. 2018; 10: 1440-1681. DOI 10.1111/1440-1681.12942.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Leach J., Van Tuyle G., Lin P., Schmidt-Ullrich R., Mikkelsen R. Ionizing radiation-induced, mitochondria-dependent generation of reactive oxygen/nitrogen. Cancer Research. 2001; 61(10): 3894-3901.</mixed-citation><mixed-citation xml:lang="en">Leach J., Van Tuyle G., Lin P., Schmidt-Ullrich R., Mikkelsen R. Ionizing radiation-induced, mitochondria-dependent generation of reactive oxygen/nitrogen. Cancer Research. 2001; 61(10): 3894-3901.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Mihandoost E., Shirazi A. Can melatonin help us in radiation oncology treatments? Biomed Res Int. 2014: 578137. DOI 10.1155/2014/578137.</mixed-citation><mixed-citation xml:lang="en">Mihandoost E., Shirazi A. Can melatonin help us in radiation oncology treatments? Biomed Res Int. 2014: 578137. DOI 10.1155/2014/578137.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Khan S., Adhikari J., Rizvi M., Chaudhury N. Radioprotective potential of melatonin against Co γ-ray-induced testicular injury in male C57BL/6 mice. Journal of Biomedical Science. 2015; 22: 1-15. DOI 10.1186/s12929-015-0156-9.</mixed-citation><mixed-citation xml:lang="en">Khan S., Adhikari J., Rizvi M., Chaudhury N. Radioprotective potential of melatonin against Co γ-ray-induced testicular injury in male C57BL/6 mice. Journal of Biomedical Science. 2015; 22: 1-15. DOI 10.1186/s12929-015-0156-9.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Ma Z., Yang Y., Fan C., Han J., Wang D., Di S. Melatonin as a potential anticarcinogen for non-small-cell lung cancer. Oncotarget. 2016; 7(29): 46768-46784. DOI 10.18632/oncotarget.8776.</mixed-citation><mixed-citation xml:lang="en">Ma Z., Yang Y., Fan C., Han J., Wang D., Di S. Melatonin as a potential anticarcinogen for non-small-cell lung cancer. Oncotarget. 2016; 7(29): 46768-46784. DOI 10.18632/oncotarget.8776.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Chakrabarti S., Morton J.S., Davidge S.T. Mechanisms of estrogen effects on the endothelium: an overview. Can J Cardiol. 2014; 30(7): 705-12. DOI 10.1016/j.cjca.2013.08.006.</mixed-citation><mixed-citation xml:lang="en">Chakrabarti S., Morton J.S., Davidge S.T. Mechanisms of estrogen effects on the endothelium: an overview. Can J Cardiol. 2014; 30(7): 705-12. DOI 10.1016/j.cjca.2013.08.006.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
